Crystalline polymorphs of a CXCchemokine receptor ligand

Details for Australian Patent Application No. 2005210504 (hide)

Owner Schering Corporation

Inventors Yin, Jianguo; Fu, Xiaoyong; Dwyer, Michael; Kim-Meade, Agnes; Zhang, Shuyi; Hu, Mengwei; Yu, Younong; Taveras, Arthur G.; McAllister, Timothy; Klopfer, Kevin

Agent Griffith Hack

Pub. Number AU-B-2005210504

PCT Pub. Number WO2005/075447

Priority 60/540,487 30.01.04 US

Filing date 28 January 2005

Wipo publication date 18 August 2005

Acceptance publication date 8 January 2009

International Classifications

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

C07D 307/52 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

10 August 2006 PCT application entered the National Phase

  PCT publication WO2005/075447 Priority application(s): WO2005/075447

8 January 2009 Application Accepted

  Published as AU-B-2005210504

7 May 2009 Standard Patent Sealed

11 October 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210509-Method and device for determining parameters of a fluctuating flow

2005210503-Genes associated with canine osteoarthritis and related methods and compositions